November 12-RNA Institute at UAlbany and Riboclub Sherbrooke

Value of the Information & Strength of the Argument

The seminar provides valuable insights into two cutting-edge areas of RNA research. Royzen’s talk presents a novel approach to control CRISPR-Cas9 activity, with clear experimental evidence supporting the feasibility of the method. The argumentation is logical and well-supported by gel electrophoresis data and cell-based assays. Massé’s talk offers a comprehensive overview of the role of small RNAs in bacterial iron metabolism and antibiotic resistance, backed by extensive research from his lab. The argumentation is compelling, linking molecular mechanisms to clinical implications. Both speakers effectively communicate complex concepts, making the seminar informative for a specialized audience.

Scientific Rigor, Source Quality, Title Accuracy

The seminar demonstrates high scientific rigor. Royzen references his own published work and collaborations, and the experimental design is robust. Massé cites the WHO report on antibiotic resistance and discusses his own published findings. The title accurately reflects the content, and the seminar is well-structured. The presence of a Q&A session adds to the credibility. No commercial biases were detected.

The title accurately reflects the content: a collaborative seminar featuring two talks on RNA-related topics.

8/10

The seminar presents original research from two established labs, with detailed experimental data and references to published work. The speakers are experts in their fields, and the content is technically rigorous. However, as a seminar, it lacks peer review and some claims are preliminary.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 02:00Introduction of Dr. Royzen and his talk on temporal control of CRISPR-Cas9.
• 05:00Royzen explains the use of click chemistry to synthesize sgRNA.
• 10:00Royzen discusses the optimization of conjugation positions for sgRNA activity.
• 20:00Royzen presents the strategy to inactivate CRISPR-Cas9 using TCO suppressors.
• 30:00Royzen shows results of in vitro and in cell experiments demonstrating temporal control.
• 40:00Introduction of Prof. Massé and his talk on small RNAs and antibiotic resistance.
• 45:00Massé discusses the global threat of antimicrobial resistance and the role of iron in bacterial virulence.
• 55:00Massé explains the function of RyhB small RNA in iron sparing and its potential link to antibiotic resistance.
• 1:05:00Massé concludes with future directions and the importance of understanding small RNA networks.

• RNA Institute at UAlbany — Host institution for the seminar and Royzen's affiliation.
• RiboClub Sherbrooke — Co-host of the seminar and Massé's affiliation.

• WHO report on antimicrobial resistance — Cited by Massé to highlight the global threat of AMR.